Menopause Publishes Pivotal Trial Results for Brisdelle

barbara.lempert Menopause Publishes Pivotal Trial Results for Brisdelle™ (Paroxetine) Capsules, an FDA-Approved Non-Hormonal Therapy for Vasomotor Symptoms Associated with ...

South Africa’s Aspen reports head-turning results

Eric Palmer While some of the biggest names in drugmaking are having a hard time growing their bottom lines, South Africa's Aspen Pharmacare Holdings is seeing the kind of growth ...

Adocia: Activity and results for the first half of 2013

barbara.lempert Intensification of R&D activity ahead of the launch of three clinical trials for insulin projects, starting in the second half of 2013 Net result of EUR -4.6 million ...

Astex reports positive PhII results for leukemia drug

Emily Mullin Dublin, CA-based Astex Pharmacueticals revealed Wednesday morning that its small molecule SGI-110 showed "clear activity" in a Phase II trial of patients with ...

Roche’s gRED sees promising results in PhII macular degeneration study

John Carroll Investigators say that lampalizumab slowed progression of AMD in patients with advanced disease, shrinking the area of geographic atrophy by 20.4%. AMD is a leading cause ...

iCo Therapeutics Announces Second Quarter 2013 Financial Results

barbara.lempert VANCOUVER, Aug. 26, 2013 /CNW/ – iCo Therapeutics (TSX-V: ICO), today reported financial results for the quarter ended June 30, 2013. Amounts, unless specified ...

SYGNIS reports half-year results for the period ended 30 June 2013

barbara.lempert •    Significant decrease in total costs and expenses by 44% •    Operating result improved by 65% •    New shareholder loan granted •    US ...

Isotechnika Reports Second Quarter 2013 Financial Results

barbara.lempert Edmonton, Alberta – August 13, 2013 (ISA:TSX):  Isotechnika Pharma Inc. (the “Company”) has released its financial results for the second quarter ...

Florida Hospital Association Releases Five-Year Results of Statewide Quality Initiatives

barbara.lempert Florida’s hospitals reduce readmissions, surgical complications and infections, save lives and millions of dollars. State awarded prestigious American Hospital ...

MannKind soars after inhaled Afrezza delivers positive PhIII results

John Carroll After being dogged by regulatory setbacks and demands for new trials, MannKind says it gathered clearly positive late-stage data on its inhaled insulin Afrezza from a pair ...

Amorfix Announces Fiscal 2014 First Quarter Results

barbara.lempert TORONTO, Aug. 13, 2013 /CNW/ – Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today ...

Acasti Announces Positive Phase II Open Label Clinical Trial Results

barbara.lempert LAVAL, Quebec, Aug. 13, 2013 (GLOBE NEWSWIRE) — Acasti Pharma (“Acasti” or the “Corporation”) (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS